Hematopoietic progenitor cells (HPC, cord blood, New York Blood Center)

N/A

Report date: 2024/01/25 10:49:11

Base Information

Drug NameHematopoietic progenitor cells (HPC, cord blood, New York Blood Center)
Drug Alias Name脐带血造血祖细胞 (HPC, cord blood, New York Blood Center)造血祖细胞（HPC，脐带血）Hemacord
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsHematopoietic stem cell transplantation (HSCT)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/11/10
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNew York Blood Center (Nybc)
China Registration ClassN/A

Develop Information

Active CompaniesNew York Blood Center (Nybc)
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeB05AX04
Related LinksDrugBank